今年的十大发现:神经退行
1Neuropathology Brain Bank & Research CoRE, Department of Pathology, Nash Family Department of Neuroscience, Ronald M. Loeb Center for Alzheimer's Disease, Friedman Brain Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Free neuropathology
|June 7, 2023
概括
本文回顾了2019年神经退行性神经病理学的进展,强调了变革性的发现和工具. 它强调协作努力和阿尔茨海默氏症以外的各种疾病类别,旨在改善对大脑疾病的理解和诊断.
科学领域:
- 神经退行性疾病研究
- 神经病理学神经病理学
- 神经科学是一个神经科学.
背景情况:
- 神经退行性疾病的科学进展需要审查具有影响力的贡献.
- 2019年近期的进展为神经病理学带来了变革的潜力.
- 增加的资金扩大了阿尔茨海默病的研究,需要更广泛地关注其他神经退行性疾病.
研究的目的:
- 从2019年开始,突显神经退行性神经病理学的有影响力的进展.
- 展示变革性的发现,工具和方法.
- 确保在各种神经退行性疾病中提供平衡的视角,而不仅仅关注阿尔茨海默病.
主要方法:
- 从2019年开始,回顾最新的科学文献和研究趋势.
- 识别合作努力和突破性的方法.
- 选择了十个关键主题,与神经病理学家和临床神经科学家相关.
主要成果:
- 引入一个新的神经退行性疾病类别.
- 单细胞基因表达分析和综合组织学-基因表达分析的新方法.
- 深度机器学习和计算机视觉在神经退行性疾病研究中的应用.
- 在阿尔茨海默病中确定神经病理与睡眠障碍的联系.
- 对阿尔茨海默氏症候选病原体的探索.
- 针对小脑神经退行症的高级形态测量分析.
- 有证据表明神经退行与接触体育有关.
- 在帕金森病中,越来越多的证据表明肠到中枢神经系统的传播.
- 专注于质细胞在亨廷顿病中的作用.
结论:
- 2019年精选的进展为提高神经退行性脑疾病的理解和诊断提供了显著的潜力.
- 审查强调了多样化的研究领域和创新的方法的重要性.
- 未来的研究应该继续探索新的方法和广泛的神经退行性疾病.
相关概念视频
01:22Alzheimer's Disease: Treatment
224
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
224
01:26Alzheimer's Disease: Overview
536
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
536
01:15Neurogenesis and Regeneration of Nervous Tissue
886
In the CNS, neurogenesis, the birth of new neurons from stem cells, is limited to the hippocampus in adults. In other regions of the brain and spinal cord, neurogenesis is almost non-existent due to inhibitory influences from neuroglia, especially oligodendrocytes, and the absence of growth-stimulating cues. The myelin produced by oligodendrocytes in the CNS inhibits neuronal regeneration. Furthermore, astrocytes proliferate rapidly after neuronal damage, forming scar tissue that physically...
886
01:15Parkinson's Disease: Overview
612
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
612